FINANCIAL STATEMENT ANALYSIS

USED BY US DEPARTMEN OF EDUCATION, UNIVERSITIES, STUDENTS & ACCOUNTING PRO'S

VentureLine tracks and provides 5-year financial statement analysis on approximately 7,000+ publicly traded companies; the SEC-traceable data is updated weekly. For your convenience you can access that current company financial statement analysis information by clicking directly on the Company Name, visit their Website or enter the Company name or Ticker symbol, e.g. enter 'Microsoft' or 'MSFT' for Microsoft, in the Company Search window below.

FINANCIAL STATEMENT ANALYSIS UPDATED: JULY 24, 2022

Results 151 through 200 of 266

- SIC # 2830

Ticker Exchange Company Financial Reports SIC #
LEXX Nasdaq Lexaria Bioscience Corp. 2830
LFCR Nasdaq Lifecore Biomedical, Inc. 2830
LKFT Nasdaq Lakefront Biotherapeutics NV 2830
LNAI Nasdaq Lunai Bioworks Inc. 2830
LQDA Nasdaq Liquidia Corporation 2830
LRMR Nasdaq Larimar Therapeutics, Inc. 2830
LSTA Nasdaq Lisata Therapeutics, Inc. 2830
MAZE Nasdaq Maze Therapeutics, Inc. 2830
MBX Nasdaq MBX Biosciences, Inc. 2830
MCRB Nasdaq Seres Therapeutics, Inc. 2830
MGTX Nasdaq MeiraGTx Holdings plc 2830
MIRA Nasdaq MIRA Pharmaceuticals, Inc. 2830
MIST Nasdaq Milestone Pharmaceuticals Inc. 2830
MLYS Nasdaq Mineralys Therapeutics, Inc. 2830
MNOV Nasdaq MediciNova, Inc. 2830
MPLT Nasdaq MapLight Therapeutics, Inc. 2830
MREO Nasdaq Mereo BioPharma Group plc 2830
MRNA Nasdaq Moderna, Inc. 2830
MTNB NYSE American Matinas BioPharma Holdings, Inc. 2830
MXCT Nasdaq MaxCyte, Inc. 2830
NAMS Nasdaq NewAmsterdam Pharma Company N.V. 2830
NATR Nasdaq Natures Sunshine Products, Inc. 2830
NBTX Nasdaq Nanobiotix S.A. 2830
NGNE Nasdaq Neurogene Inc. 2830
NIKI Nasdaq Niki BioSolutions, Inc. 2830
NMRA Nasdaq Neumora Therapeutics, Inc. 2830
NNVC NYSE American NanoViricides, Inc. 2830
NSRX NYSE American Nasus Pharma Ltd. 2830
NTRB Nasdaq Nutriband Inc. 2830
NUVB New York Nuvation Bio Inc. 2830
NVO New York Novo Nordisk A/S 2830
NVS New York Novartis AG 2830
NXTC Nasdaq NextCure, Inc. 2830
NXTS Nasdaq Nexentis Technologies Inc. 2830
OCS Nasdaq Oculis Holding AG 2830
ODTX Nasdaq Odyssey Therapeutics, Inc. 2830
OGN New York Organon & Co. 2830
OMER Nasdaq Omeros Corporation 2830
ONCY Nasdaq Oncolytics Biotech Inc. 2830
ORINY Over the counter Orion Oyj 2830
ORXOY Over the counter Orexo AB (publ) 2830
OVID Nasdaq Ovid Therapeutics Inc. 2830
PASG Nasdaq Passage Bio, Inc. 2830
PBM Nasdaq Psyence Biomedical Ltd. 2830
PCSA Nasdaq Processa Pharmaceuticals, Inc. 2830
PCVX Nasdaq Vaxcyte, Inc. 2830
PDSB Nasdaq PDS Biotechnology Corporation 2830
PFE New York Pfizer Inc. 2830
PG New York The Procter & Gamble Company 2830
PHAR Nasdaq Pharming Group N.V. 2830
Results 150 through 200 of 266